Effect of the final rule on the conduct of emergency clinical research

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue 6, 2008, Pages 1665-1672

  Gonzalez, Stephanie K ^a   Helling, Thomas S ^a  

^a Department of Pharmaceutical Care Services   (United States)

Author keywords

Informed consent; Research; Trauma

Indexed keywords

ATTITUDE; CLINICAL RESEARCH; COMMUNITY; CONSULTATION; EMERGENCY; EMERGENCY CARE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; INFORMED CONSENT; KNOWLEDGE; MILITARY RESEARCH; MORTALITY; PEDIATRICS; PERCEPTION; POPULATION; PRIORITY JOURNAL; REVIEW; TRUST; CLINICAL PROTOCOL; EMERGENCY MEDICINE; FEMALE; HUMAN EXPERIMENT; LEGAL ASPECT; MALE; MANAGEMENT; MEDICAL RESEARCH; STANDARD; UNITED STATES;

BIOMEDICAL RESEARCH; CLINICAL PROTOCOLS; EMERGENCY MEDICINE; FEMALE; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MALE; POLICY MAKING; PRESUMED CONSENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 67650330010     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31817156ce     Document Type: Review

References (29)

1. Office for Protection From Research Risks Report 97-01. Washington, DC: Department of Health and Human Services; 1996.
2. Biros M. Research without consent: current status, 2003. Ann Emerg Med. 2003;42:550-564.
3. U.S. Department of Health and Human Services, Food and Drug Administration (March 2000). Guidance for institutional review boards, clinical investigators, and sponsors: Exception from informed consent requirements for emergency research (21 CFR 50.24). Available at: http://www.fda.gov/ora/ compliance-ref/bimoJ emrfinal.pdf.
4. Lewis R. Prehospital care of the multiply injured patient: the challenge of figuring out what works. JAMA. 2004;291:1382-1384.
5. U.S. Department of Health and Human Services, Food and Drug Administration (2006). Regulations and Guidance on the Protection of Human Subjects: Clinical Investigator, IRB, and Sponsor Responsibilities: exception from informed consent requirements for emergency research. Clinical Research Resources, LLC, Philadelphia, pp 63-73.
6. Goldkind S, Kaneshiro J, Shapiro R, Sugarman J. When and how to seek an emergency exception to informed consent. 2006 Annual HRPP Conference. Washington, DC; November 16, 2006.
7. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: Office for Protection from Research Risks; 1979.
8. Lewis R, Berry D, Cryer H, et al. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Ann Emerg Med. 2001;38:397-404.
9. Sloan E, Koenigsberg M, Houghton J, et al. The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin. Acad Emerg Med. 1999;6:1203-1208.
10. Sloan EP, Koenigsberg M, Gens D, et al; DCLHb Traumatic Hemorrhagic Shock Study Group. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999;282:1857-1864.
11. Lunstroth J. Acting out of ethics: what the open letter asks. Am J Bioeth. 2006;6:41-43.
12. Kipnis K, King N, Nelson R. An open letter to institutional review boards considering Northfield laboratories' PolyHeme trial. Am J Bioeth. 2006;6:18-21.
13. Derse A. Emergency research and consent: keeping the exception from undermining the rule. Am J Bioeth. 2006;6:36-37.
14. Holloway K. Accidental communities: race, emergency medicine and the problem of PolyHeme. Am J Bioeth. 2006;6:7-17.
15. McClure K, Delorio N, Gunnels M, Ochsner M, Biros M, Schmidt T. Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation, and public notification. Acad Emerg Med. 2003;10:352-359.
16. Shah A, Sugarman J. Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med. 2003; 41:72-78.
17. Dula A. Bearing the brunt of the new regulations: minority populations. Hastings Cent Rep. 1997;27:11-12.
18. Richardson L. The ethics of research without consent in emergency situations. Mt Sinai J Med. 2005;72:242-249.
19. Steeves P. "Start a line and get me a consent waiver, STAT!" Autonomy, community consultation, and informed consent in emergency research. Queen: J Rhetoric Power. Available at: http://www.ars-rhetoricanet/Queen/ VolumeSpeciallssue/Articles/Steeves.pdf.
20. Morris M, Nadkarni V, Ward F, Nelson R. Exception from informed consent for pediatric resuscitation research: community consultation for a trial of brain cooling after in-hospital cardiac arrest. Pediatrics. 2004;114:776-781.
21. Hiller K, Haukoos J, Heard K, Tashkin J, Paradis N. Impact of the final rule on the rate of clinical cardiac arrest research in the United States. Acad Emerg Med. 2005;12:1091-1098.
22. Sava J, Ciesla D, Williams M, Street J III, White P, Wang D. Is informed consent in trauma a lost cause? A prospective evaluation of acutely injured patients' ability to give consent. J Am Coll Surg. 2007;205:405-408.
23. Richardson L, Wilets I, Ragin D, et al. Research without consent: community perspectives from the community VOICES study. Acad Emerg Med. 2005;12:1082-1090.
24. Marshall P, Berg J. Protecting communities in biomedical. Am J Bioeth. 2006;6:28-30.
25. Orr RD. Rules is rules. Am J Bioeth. 2006;6:40-41.
26. Kipnis K, King N, Nelson R. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. IRB. 2006;28:16-19.
27. Morris M. An ethical analysis of exception from informed consent regulations. Acad Emerg Med. 2005;12:1113-1119.
28. U.S. Department of Health and Human Services, Health Resources and Services Administration Office of Special Programs, Division of Transportation. (August 2002). Guidance for donor registry development conference final report. Available at: www.organdonor.gov/nfdrguidelines.html.
29. Halperin H, Paradis N, Mosesso V Jr, et al. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration's "exceptions from informed consent requirements for emergency research." Circulation. 2007;116:1855-1863.